| Style | Citing Format |
|---|---|
| MLA | Rad MR, et al.. "Baricitinib in Covid-19; a Letter to Editor on Recent Findings." Journal of Parathyroid Disease, vol. 9, no. , 2021, pp. -. |
| APA | Rad MR, Dabaghi GG, Rahvard HV, Jahantigh HR (2021). Baricitinib in Covid-19; a Letter to Editor on Recent Findings. Journal of Parathyroid Disease, 9(), -. |
| Chicago | Rad MR, Dabaghi GG, Rahvard HV, Jahantigh HR. "Baricitinib in Covid-19; a Letter to Editor on Recent Findings." Journal of Parathyroid Disease 9, no. (2021): -. |
| Harvard | Rad MR et al. (2021) 'Baricitinib in Covid-19; a Letter to Editor on Recent Findings', Journal of Parathyroid Disease, 9(), pp. -. |
| Vancouver | Rad MR, Dabaghi GG, Rahvard HV, Jahantigh HR. Baricitinib in Covid-19; a Letter to Editor on Recent Findings. Journal of Parathyroid Disease. 2021;9():-. |
| BibTex | @article{ author = {Rad MR and Dabaghi GG and Rahvard HV and Jahantigh HR}, title = {Baricitinib in Covid-19; a Letter to Editor on Recent Findings}, journal = {Journal of Parathyroid Disease}, volume = {9}, number = {}, pages = {-}, year = {2021} } |
| RIS | TY - JOUR AU - Rad MR AU - Dabaghi GG AU - Rahvard HV AU - Jahantigh HR TI - Baricitinib in Covid-19; a Letter to Editor on Recent Findings JO - Journal of Parathyroid Disease VL - 9 IS - SP - EP - PY - 2021 ER - |